Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and The CHEST Foundation
Johann C. Brandes, MD, PhD
Emory University
Atlanta
GA
The CHFR gene is a gene that has undergone changes in its DNA. Dr. Brandes is studying how the CHFR gene predicts a non-small cell lung cancer patient’s response to chemotherapy.